1. Home
  2. Vol 56, No 3 (2024)
  3. Sania

Risk Factors Associated with the Colonization of Multidrug-Resistant Gram-Negative Bacteria Upon Admission to the Intensive Care Unit: A Cross-sectional Study

Nina Sania, Yulia Rosa Saharman, Delly Chipta Lestari, Dita Aditianingsih, Andi Yasmon

Abstract


Background: Multidrug-resistant Gram-negative bacteria (MDR-GNB) are prevalent in intensive care units (ICUs), leading to increased morbidity and mortality. Limited data on MDR-GNB in Indonesia prompted this study to determine the prevalence and risk factors associated with MDR-GNB colonization, enhancing screening strategies, and acquiring phenotypic and genotypic data on these bacteria. Methods: This analytical cross-sectional observational study included participants who met the criteria and were admitted to the ICU at Dr. Cipto Mangunkusumo Hospital from January to December 2022. We used multivariate analysis on the findings from rectal swab screening, sociodemographic, clinical, and microbiological examinations. Results: Out of 108 participants, 172 cultures comprised 165 Gram-negative isolates, four yeasts, and three with no growth. The prevalence of patients colonized with MDR-GNB was 51.85% (56/108), and the prevalence of MDR-GNB isolates was 39.53% (68/172), with the most common MDR-GNB being Escherichia coli (29.65%) and Klebsiella pneumoniae (19.44%). The most resistant gene found in ESBL was CTX-M (75%), and the carbapenemase producer gene was NDM (5.88%). Risk factors associated with MDR-GNB colonization were the length of stay before admission to the ICU (p = 0.003) and a history of previous antibiotic therapy (p = 0.036). Conclusion: In this study, two risk factors were associated with the occurrence of MDR-GNB colonization, with the prevalence of MDR-GNB colonization in patients initially admitted to the ICU still quite high. Therefore, selecting screening patients based on risk factors at the time of initial admission to the ICU is crucial for infection control programs.


Keywords


MDR-GNB bacteria; risk factors; resistance genes; colonization; prevalence; screening

References


Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.

Lawe-Davies O, Bennett S (WHO). WHO publishes list of bacteria for which new antibiotics are urgently needed. Saudi Med J. 2017;38:444–5.

Kumalawati J, Sukartini N, Handimulya D, Solin Ro S, Bahasoan Y. Bacterial and antibiotics susceptibility profile at Cipto Mangunkusumo General Hospital January – June 2022. Jakarta; 2022.

Willems RPJ, van Dijk K, Vehreschild MJGT, et al. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. Lancet Infect Dis. 2023;23(6):719–31.

Denkel LA, Maechler F, Schwab F, et al. Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae. Clin Microbiol Infect. 2020;26(8):1046–51.

Tischendorf J, De Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobacteriaceae: A systematic review. Am J Infect Control. 2016;44(5):539–43.

Massart N, Camus C, Benezit F, Moriconi M, Fillatre P, Le Tulzo Y. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate. Eur J Clin Microbiol Infect Dis. 2020;39(5):889–95.

Saharman YR, Lestari DC. Phenotype characterization of Beta-lactamase producing Enterobacteriaceae in the intensive care unit (ICU) of Cipto Mangunkusumo Hospital in 2011. Acta Med Indones. 2013;45(1):11–6.

Karuniawati A, Saharman YR, Lestari DC. Detection of Carbapenemase Encoding Genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii Isolated from Patients at Intensive Care Unit Cipto Mangunkusumo Hospital in 2011. Acta Med Indones. 2013;45:101–6.

Saharman YR. ICU-acquired Carbapenem-non-susceptible Bacilli in Indonesia Focus on : Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa. Erasmus University Rotterdam; 2020. Available from: http://hdl.handle.net/1765/132401

Razazi K, Derde LPG, Verachten M, Legrand P, Lesprit P, Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum β-lactamaseproducing bacteria in the intensive care unit. Intensive Care Med. 2012;38(11):1769–78.

ECDC. Risk assessment on the spread of carbapenemase producer Enterobacteriacae (CPE). Ecdc. 2011.

ECDC. Last-line antibiotics are failing: options to address this urgent threat to patients and healthcare systems. Ecdc Policy Brief. 2016.

Dembélé R, Konaté A, Traoré O, et al. Extended spectrum beta-lactamase and fluoroquinolone resistance genes among Escherichia coli and Salmonella isolates from children with diarrhea, Burkina Faso. BMC Pediatr. 2020;20(1):459.

Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–23.

Fouda R, Soliman MS, ElAnany MG, Abadeer M, Soliman G. Prevalence and risk factors of MRSA, ESBL and MDR bacterial colonization upon admission to an Egyptian medical ICU. J Infect Dev Ctries. 2016;10(4):329–36.

Fernández-Martínez NF, Cárcel-Fernández S, De la Fuente-Martos C, et al. Risk factors for multidrug-resistant Gram-negative bacteria carriage upon admission to the intensive care unit. Int J Environ Res Public Health. 2022;19(3):1–13.

Alagna L, Palomba E, Mangioni D, et al. Multidrug‐resistant gram‐negative bacteria decolonization in immunocompromised patients: A focus on fecal microbiota transplantation. International Journal of Molecular Sciences. MDPI AG. 2020;21:1–22.

Naelasari DN, Koendhori EB, Dewanti L, Sarassari R, Kuntaman K. The prevalence of extended spectrum beta-lactamase (ESBL) producing gut bacterial flora among patients in Dr. Soetomo Hospital and Primary Health Centre in Surabaya. Folia Medica Indones. 2018;54(4):256.

Anggraini D, Santosaningsih D, Saharman YR, et al. Distribution of carbapenemase genes among carbapenem-non-susceptible acinetobacter baumanii blood isolates in Indonesia: A multicenter study. Antibiotics. 2022;11(3):366.

Kuntaman K, Shigemura K, Osawa K, et al. Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan. Int J Urol. 2018;25(11):966–72.

Ang H, Sun X. Risk factors for multidrug‐resistant Gram‐negative bacteria infection in intensive care units: A meta‐analysis. Int J Nurs Pract. 2018;24(4):1–13.

Azzini AM, Be G, Naso L, et al. Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting. Front Cell Infect Microbiol. 2023;13:1155320.

2Elsorady KE. Predictors of multi-drug resistant Gram-negative bacterial infection in critically ill older adults. Aging Med Healthc. 2022;13(1):32–9.

Schoevaerdts D, Sibille FX, Gavazzi G. Infections in the older population: what do we know? Aging Clinical and Experimental Research. Springer Science and Business Media Deutschland GmbH. 2021;33:689–701.

Asare Yeboah EE, Agyepong N, Mbanga J, et al. Multidrug-resistant Gram-negative bacterial colonization in patients, carriage by healthcare workers and contamination of hospital environments in Ghana. J Infect Public Health. 2023;16(1)2-8.

Kizilates F, Yakupogullari Y, Berk H, Oztoprak N, Otlu B. Risk factors for fecal carriage of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains among patients at hospital admission. Am J Infect Control. 2021;49(3):333–9.

Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother. 2012;67(12):2976–81.

Palacios-Baena ZR, Giannella M, Manissero D, et al. Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. Clinical Microbiology and Infection. Elsevier B.V. 2021;27:228–35.

Tseng WP, Chen YC, Chen SY, Chen SY, Chang SC. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018;7:93.

Maina JW, Onyambu FG, Kibet PS, Musyoki AM. Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study. Ann Clin Microbiol Antimicrob. 2023;22(1):85.

Ceccarelli G, Alessandri F, Moretti S, et al. Clinical impact of colonization with Carbapenem-resistant Gram-negative bacteria in critically ill patients admitted for severe trauma. Pathogens. 2022;11(11):1295.

De Oliveira Costa P, Atta EH, da Silva ARA. Predictors of 7- and 30-day mortality in pediatric intensive care unit patients with cancer and hematologic malignancy infected with Gram-negative bacteria. Brazilian J Infect Dis. 2014;18(6):591–9.

Mangioni D, Chatenoud L, Colombo J, et al. Multidrug-resistant bacterial colonization and infections in large retrospective cohort of mechanically ventilated COVID-19 patients. Emerg Infect Dis. 2023;29(8):1598–607.

Alexiou VG, Michalopoulos A, Makris GC, Peppas G, Samonis G, Falagas ME. Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: A cohort study. Eur J Clin Microbiol Infect Dis. 2012;31(4):557–66.

Matos JA de, Gomes A da S, Lima COGX, et al. Systematic review on efficacy of preventive measures for surgical site infection by multiple-drug resistant Gram-negative Bacilli. Brazilian J Infect Dis. 2022;26(6):102705.

Althaqafi A, Yaseen M, Farahat F, Munshi A, Al-Amri A, Essack SY. Risk factors for infection with multidrug-resistant Gram-negative bacteria in a tertiary care hospital in Saudi Arabia: A case-control study. Cureus. 2023;15(4):e37291.

Cassone M, Mody L. Colonization with multidrug-resistant organisms in nursing homes: Scope, importance, and management. Curr Geriatr Reports. 2015;4(1):87–95.

de Macedo V, dos Santos G de S, da Silva RN, Couto CN de M, Bastos C, Viecelli E, et al. The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19. Clinics. 2022;77:100130.

Rattanaumpawan P, Choorat C, Takonkitsakul K, Tangkoskul T, Seenama C, Thamlikitkul V. A prospective surveillance study for multidrug-resistant bacteria colonization in hospitalized patients at a Thai University Hospital. Antimicrob Resist Infect Control. 2018;7:102.

Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(S1):1–55.

Viau R, Frank KM, Jacobs MR, et al. Intestinal carriage of Carbapenemase producer organisms: Current status of surveillance methods. Clinical Microbiology Reviews. 2016; 29:1–27.

Kibwana UO, Majigo M, Kamori D, Manyahi J. High fecal carriage of Extended Beta Lactamase producing Enterobacteriaceae among adult patients admitted in Referral Hospitals in Dar es salaam, Tanzania. 2020;20(1):557.


Full Text: PDF

Refbacks

  • There are currently no refbacks.